(Press-News.org) Potentially more than 90% of Alzheimer’s disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by UCL researchers.
The scientists also found that close to half of all dementia cases would probably not arise without the gene’s influence.
The researchers say that the findings, published today in npj Dementia, highlight this gene (and the protein it produces) as a powerful yet under-recognised target for drug development, which could have the scope to prevent or treat a large proportion of all dementia.
The APOE gene has long been implicated in Alzheimer’s disease. There are three common types (alleles) of the gene, known as ε2, ε3, and ε4. Everyone carries two APOE genes, creating six different combinations* of the ε2, ε3, and ε4 variants. In the 1990s, geneticists established that people carrying one or more ε4 variant face a much greater risk of Alzheimer’s than those with two copies of the more commonly inherited ε3 variant, and that groups with ε2 experience less risk relative to the ε3 carriers.
Lead author Dr Dylan Williams (UCL Division of Psychiatry and Unit for Lifelong Health and Ageing at UCL) said: “We have long underestimated how much the APOE gene contributes to the burden of Alzheimer’s disease. The ε4 variant of APOE is well recognised as harmful by dementia researchers, but much disease would not occur without the additional impact of the common ε3 allele, which has been typically misperceived as neutral in terms of Alzheimer’s risk.
“When we consider the contributions of ε3 and ε4, we can see that APOE potentially has a role in almost all Alzheimer’s disease. Consequently, if we knew how to reduce the risk that the ε3 and ε4 variants confer to people, we may be able prevent most disease from occurring.”
The study is the most comprehensive modelling to date of the proportion of Alzheimer's and dementia cases that arise across the population due to common variation in APOE. The researchers pulled together evidence of how much the ε3 and ε4 alleles are linked to an increased risk of Alzheimer’s disease, any form of dementia, and the brain changes that lead to Alzheimer’s. Key to this study was the use of datasets from four extremely large studies (with a total of over 450,000 participants) that enabled them to find many people in the uncommon group with two copies of the ε2 variant, and use this group as a low-risk baseline in their calculations for the first time in such an analysis.
The researchers estimated that 72-93% of Alzheimer’s cases would not have occurred if it weren’t for the ε3 and ε4 alleles of the APOE gene, and approximately 45% of all dementia cases would not arise without the gene’s influence. These estimates are higher than previous estimates of APOE’s influence, mainly because the researchers in the latest study were considering the roles of both ε3 and ε4 variants.
The variation between findings from the four studies was due to differences in how each defined and measured Alzheimer's and dementia (including recorded diagnoses of Alzheimer’s disease or other dementias, or evidence of amyloid pathology from brain scans), as well as differences in follow-up periods and potential biases in study recruitment. Taken together, evidence from all sources suggested that APOE is most likely responsible for at least three in four Alzheimer’s cases, and possibly more.
The findings suggest the APOE gene should be prioritised in mechanistic and drug discovery research.
Dr Williams said: “There has been major progress in recent years in gene editing and other forms of gene therapy to target genetic risk factors directly. Moreover, genetic risk also points us towards parts of our physiology that we could target with more conventional drugs. Intervening on the APOE gene specifically, or the molecular pathway between the gene and the disease, could have great, and probably under-appreciated, potential for preventing or treating a large majority of Alzheimer’s disease.
“The extent to which APOE has been researched in relation to Alzheimer’s or as a drug target has clearly not been proportionate to its full importance.”
Alzheimer’s and other dementia diseases are not caused solely by the APOE gene, as even in the rare, highest-risk category – people with two copies of ε4 – lifetime risk of Alzheimer’s disease is still estimated to be below 70%.
As Dr Williams explained: “Most people with genetic risk factors like APOE ε3 and ε4 won’t get dementia in a typical lifetime, since there are complicated interactions at play with other contributing genetic and environmental risk factors. Understanding what modifies the risk people inherit from their APOE genes is another crucial question for dementia researchers to grapple with.
“For instance, other research has suggested that perhaps half of dementia incidence could be prevented or delayed by improving many modifiable risk factors such as social isolation, high cholesterol or smoking, across populations.** With complex diseases like Alzheimer's and other diseases that cause dementia, there will be more than one way to reduce disease occurrence. We should explore many options by which we might modify Alzheimer’s and dementia risk, including but not limited to strategies related to APOE.
“Nonetheless, we should not overlook the fact that without the contributions of APOE ε3 and ε4, most Alzheimer’s disease cases would not occur, irrespective of what other factors are inherited or experienced by carriers of these variants throughout life.”
The study, conducted by researchers at UCL and the University of Eastern Finland, was supported by funding from Alzheimer’s Research UK, the Medical Research Council and others.
Dr Sheona Scales, Director of Research at Alzheimer’s Research UK, said: “This study highlights that more Alzheimer’s cases are linked to the APOE gene that previously thought. However, not everyone with these variants will develop Alzheimer’s, demonstrating the complex relationship between genetics and other risk factors for dementia.
“Despite APOE being linked to Alzheimer’s, very few treatments in clinical trials target this gene directly. Findings from this study show that further research into APOE will be important for developing future prevention and treatment strategies for Alzheimer’s.
“Alzheimer’s Research UK is delighted to support Dr Williams as he continues to investigate how genetics alongside environmental and societal factors influence dementia risk, which will ultimately bring us closer to a cure.”
Why APOE variants are linked to dementia
Previous studies have suggested that the ε4 variant might increase dementia risk because the protein it produces is less effective at clearing harmful amyloid-beta (a sticky protein that forms plaques). It also disrupts fat and energy processing in the brain cells and promotes inflammation – changes that may gradually damage neurons and make the brain more vulnerable to Alzheimer’s and related dementias. Further research is needed to confirm these mechanisms and understand why the ε3 variant increases dementia risk relative to ε2.
* The six combinations of the APOE gene are: ε2+ε2; ε2+ε3; ε2+ε4; ε3+ε3; ε3+ε4; ε4+ε4. The variants are referred to as APOE2, APOE3, APOE4 in relation to APOE protein type.
** The Lancet Commission on dementia prevention, intervention, and care 2024 (also on UCL News)
END
Most Alzheimer’s cases linked to variants in a single gene
2026-01-09
ELSE PRESS RELEASES FROM THIS DATE:
Finding the genome's blind spot
2026-01-09
EMBARGOED UNTIL 9 January 2026, 11 AM CET, 5 AM ET
Basel, 9 January 2026 – Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with night blindness in youth and progresses to tunnel vision as daylight-sensing photoreceptor cells in the retina gradually die, potentially leading to blindness over time. Although more than a hundred genes have been linked to RP, the genetic cause remains undiagnosed in ~30-40% of patients, even after extensive DNA testing. For many families, this ...
The secret room a giant virus creates inside its host amoeba
2026-01-09
Kyoto, Japan -- A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency partially depends on the usage of a codon, or sequence of three nucleotides, that matches the cellular pool of tRNA, key molecules in translation. Using rare codons that are poorly supported by the cellular tRNA pool tends to induce ribosome pausing and mRNA instability, often weakening the virus.
Yet many eukaryotic viruses use a codon pattern that deviates from their host's while still relying on the host's translation mechanism. Theoretically this mismatch should hinder viral ...
World’s vast plant knowledge not being fully exploited to tackle biodiversity and climate challenges, warn researchers
2026-01-09
An international group of researchers says that biodiversity conservation and scientific research are not benefiting from the vast knowledge about the world’s plants held by botanic gardens, because of fragmented data systems and a lack of standardisation.
In a new report published today in the journal Nature Plants, researchers based at more than 50 botanic gardens and living plant collections warn that a patchwork of incompatible, or even absent, data systems is undermining global science and conservation at a critical moment.
They call for a unified and equitable global data ...
New study explains the link between long-term diabetes and vascular damage
2026-01-09
The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood cells may be an important explanation, and identifies a specific molecule as a possible biomarker.
People with type 2 diabetes are at increased risk of heart attack and stroke, and the risk increases the longer they have lived with the disease. Previous research has shown that red blood cells can affect blood vessel function in diabetes. Now, a new study shows that the duration of the disease plays a decisive ...
Ocean temperatures reached another record high in 2025
2026-01-09
A new international analysis published in Advances in Atmospheric Sciences on 9 January finds that the Earth’s ocean stored more heat in 2025 than in any year since modern measurements began. The 2025 heat increase was 23 Zetta Joules (23,000,000,000,000,000,000,000 Joules of energy), which is equivalent to ~37 years of global primary energy consumption at the 2023 level (~620 Exa Joules per year). The finding is the result of a major international collaboration, involving more than 50 scientists from 31 research ...
Dynamically reconfigurable topological routing in nonlinear photonic systems
2026-01-09
Topological photonics has emerged as a powerful paradigm for achieving robust light transport that is immune to imperfections, disorder, and structural defects. By harnessing principles from condensed matter physics, topological photonic systems support edge modes that guide light along boundaries without backscattering — a feature that has significant implications for resilient optical communication and information processing. However, most demonstrations of topological photonics have been confined to linear and static settings, where the transport pathways are fixed once the device is fabricated. This rigidity presents a major limitation for practical ...
Crystallographic engineering enables fast low‑temperature ion transport of TiNb2O7 for cold‑region lithium‑ion batteries
2026-01-09
As fast-charging lithium-ion batteries race toward sub-zero markets, the anode bottleneck—graphite plating risk and Li4Ti5O12 capacity ceiling—intensifies. Now, researchers from Harbin Institute of Technology, led by Prof. Yan Zhang and Prof. Shuaifeng Lou, unveil an Sb/Nb co-doped TiNb2O7 (TNO) anode that unlocks 140 mAh g-1 at 20 C and 500 stable cycles at −30 °C. Published in Nano-Micro Letters, the work delivers a practical pouch cell delivering 1.14 Ah at 17 C with 93.8 % retention ...
Ultrafast sulfur redox dynamics enabled by a PPy@N‑TiO2 Z‑scheme heterojunction photoelectrode for photo‑assisted lithium–sulfur batteries
2026-01-09
While lithium–sulfur batteries (LSBs) promise 2600 Wh kg⁻¹, the sluggish liquid-solid conversion of polysulfides keeps practical capacities far below theory. Now, researchers at Northwestern Polytechnical University, led by Prof. Yibo He, report a free-standing PPy@N-TiO2/Carbon-Cloth photocathode that harvests sunlight to co-drive sulfur redox, delivering 1 653 mAh g-1 (98.7 % of theory) and 333 mAh g-1 after 5 h of pure photo-charging. Published in Nano-Micro Letters, the work realizes dual-mode energy harvesting in a single cell.
Why Photo-Assisted Strategy Matters
Polysulfide ...
Optimized biochar use could cut China’s cropland nitrous oxide emissions by up to half
2026-01-09
Agricultural soils are one of the world’s largest sources of nitrous oxide, a greenhouse gas nearly 300 times more powerful than carbon dioxide over a century. New research suggests that a common agricultural byproduct may offer a powerful and practical solution. A study published in Biochar shows that straw-derived biochar, when applied using region-specific strategies, could reduce nitrous oxide emissions from China’s croplands by as much as 50 percent.
Nitrous oxide is primarily released from soils treated with nitrogen fertilizers. While biochar, a carbon-rich material produced by heating crop residues under low oxygen conditions, has long been ...
Neural progesterone receptors link ovulation and sexual receptivity in medaka
2026-01-09
A research team led by Hiroshima University and Tokyo University of Agriculture and Technology have proposed a neuroendocrine mechanism in bony fish that signals ovulation from the ovaries to the brain, using the medaka fish as a model; the first step to elucidate the neural circuits for facilitation of sexual receptivity in female teleosts.
Bony fish (teleosts) are one of the most diverse groups of vertebrates, inhabiting a wide variety of aquatic environments. Females of many species are sexually receptive only when eggs have developed in the ovaries and are ready for spawning. In other words, sexual ...